메뉴 건너뛰기




Volumn 6, Issue 16, 2015, Pages 14596-14613

Endoplasmic reticulum targeting in Ewing's sarcoma by the alkylphospholipid analog edelfosine

Author keywords

Apoptosis; Edelfosine; Endoplasmic reticulum; Ether phospholipid; Ewing's sarcoma; Xenograft animal model

Indexed keywords

CASPASE 9; CYTOCHROME C; EDELFOSINE; PROTEIN C JUN; REACTIVE OXYGEN METABOLITE; ANTINEOPLASTIC AGENT; ETHER PHOSPHOLIPID;

EID: 84931063432     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.4053     Document Type: Article
Times cited : (20)

References (74)
  • 1
    • 0030665020 scopus 로고    scopus 로고
    • The use of paediatric chemotherapy protocols at full dose is both a rational and feasible treatment strategy in adults with Ewing's family tumours
    • Verrill MW, Judson IR, Wiltshaw E, Thomas JM, Harmer CL, Fisher C. The use of paediatric chemotherapy protocols at full dose is both a rational and feasible treatment strategy in adults with Ewing's family tumours. Ann Oncol. 1997; 8: 1099-1105.
    • (1997) Ann Oncol , vol.8 , pp. 1099-1105
    • Verrill, M.W.1    Judson, I.R.2    Wiltshaw, E.3    Thomas, J.M.4    Harmer, C.L.5    Fisher, C.6
  • 2
    • 34447324657 scopus 로고    scopus 로고
    • The Biology of Ewing sarcoma
    • Riggi N, Stamenkovic I. The Biology of Ewing sarcoma. Cancer Lett. 2007; 254: 1-10.
    • (2007) Cancer Lett. , vol.254 , pp. 1-10
    • Riggi, N.1    Stamenkovic, I.2
  • 3
    • 47249160783 scopus 로고    scopus 로고
    • Ewing sarcoma: historical perspectives, current state-of-the-art, and opportunities for targeted therapy in the future
    • Ludwig JA. Ewing sarcoma: historical perspectives, current state-of-the-art, and opportunities for targeted therapy in the future. Curr Opin Oncol. 2008; 20: 412-418.
    • (2008) Curr Opin Oncol. , vol.20 , pp. 412-418
    • Ludwig, J.A.1
  • 4
    • 47549083691 scopus 로고    scopus 로고
    • Changes in incidence and survival of Ewing sarcoma patients over the past 3 decades: surveillance epidemiology and end results data
    • Esiashvili N, Goodman M, Marcus RB, Jr. Changes in incidence and survival of Ewing sarcoma patients over the past 3 decades: surveillance epidemiology and end results data. J Pediatr Hematol Oncol. 2008; 30: 425-430.
    • (2008) J Pediatr Hematol Oncol. , vol.30 , pp. 425-430
    • Esiashvili, N.1    Goodman, M.2    Marcus, R.B.3
  • 5
    • 84889039386 scopus 로고    scopus 로고
    • Targeted therapy in Ewing sarcoma
    • Lissat A, Chao MM, Kontny U. Targeted therapy in Ewing sarcoma. ISRN Oncol. 2012; 2012: 609439.
    • (2012) ISRN Oncol. , vol.2012 , pp. 609439
    • Lissat, A.1    Chao, M.M.2    Kontny, U.3
  • 9
    • 84890909489 scopus 로고    scopus 로고
    • Cancer stem cells in pediatric sarcomas
    • Dela Cruz FS. Cancer stem cells in pediatric sarcomas. Front Oncol. 2013; 3: 168.
    • (2013) Front Oncol. , vol.3 , pp. 168
    • Dela Cruz, F.S.1
  • 17
    • 84890682112 scopus 로고    scopus 로고
    • How to target apoptosis signaling pathways for the treatment of pediatric cancers
    • Fulda S. How to target apoptosis signaling pathways for the treatment of pediatric cancers. Front Oncol. 2013; 3: 22.
    • (2013) Front Oncol. , vol.3 , pp. 22
    • Fulda, S.1
  • 18
    • 0036783411 scopus 로고    scopus 로고
    • Biological activities, mechanisms of action and biomedical prospect of the antitumor ether phospholipid ET-18-OCH3 (Edelfosine), a proapoptotic agent in tumor cells
    • Gajate C, Mollinedo F. Biological activities, mechanisms of action and biomedical prospect of the antitumor ether phospholipid ET-18-OCH3 (Edelfosine), a proapoptotic agent in tumor cells. Curr Drug Metab. 2002; 3: 491-525.
    • (2002) Curr Drug Metab. , vol.3 , pp. 491-525
    • Gajate, C.1    Mollinedo, F.2
  • 19
    • 9144229513 scopus 로고    scopus 로고
    • ET-18-OCH3 (edelfosine): a selective antitumour lipid targeting apoptosis through intracellular activation of Fas/CD95 death receptor
    • Mollinedo F, Gajate C, Martin-Santamaria S, Gago F. ET-18-OCH3 (edelfosine): a selective antitumour lipid targeting apoptosis through intracellular activation of Fas/CD95 death receptor. Curr Med Chem. 2004; 11: 3163-3184.
    • (2004) Curr Med Chem. , vol.11 , pp. 3163-3184
    • Mollinedo, F.1    Gajate, C.2    Martin-Santamaria, S.3    Gago, F.4
  • 20
    • 52949108830 scopus 로고    scopus 로고
    • Anticancer alkylphospholipids: mechanisms of action, cellular sensitivity and resistance, and clinical prospects
    • van Blitterswijk WJ, Verheij M. Anticancer alkylphospholipids: mechanisms of action, cellular sensitivity and resistance, and clinical prospects. Curr Pharm Des. 2008; 14: 2061-2074.
    • (2008) Curr Pharm Des. , vol.14 , pp. 2061-2074
    • van Blitterswijk, W.J.1    Verheij, M.2
  • 21
    • 84908122155 scopus 로고    scopus 로고
    • Editorial: Antitumor alkylphospholipid analogs: a promising and growing family of synthetic cell membrane-targeting molecules for cancer treatment
    • Mollinedo F. Editorial: Antitumor alkylphospholipid analogs: a promising and growing family of synthetic cell membrane-targeting molecules for cancer treatment. Anticancer Agents Med Chem. 2014; 14: 495-498.
    • (2014) Anticancer Agents Med Chem. , vol.14 , pp. 495-498
    • Mollinedo, F.1
  • 22
    • 0035503414 scopus 로고    scopus 로고
    • Randomized, double-blind, placebo-controlled, multicenter trial of 6% miltefosine solution, a topical chemotherapy in cutaneous metastases from breast cancer
    • Leonard R, Hardy J, van Tienhoven G, Houston S, Simmonds P, David M, Mansi J. Randomized, double-blind, placebo-controlled, multicenter trial of 6% miltefosine solution, a topical chemotherapy in cutaneous metastases from breast cancer. J Clin Oncol. 2001; 19: 4150-4159.
    • (2001) J Clin Oncol. , vol.19 , pp. 4150-4159
    • Leonard, R.1    Hardy, J.2    van Tienhoven, G.3    Houston, S.4    Simmonds, P.5    David, M.6    Mansi, J.7
  • 23
    • 34147130359 scopus 로고    scopus 로고
    • Antitumor ether lipids: proapoptotic agents with multiple therapeutic indications
    • Mollinedo F. Antitumor ether lipids: proapoptotic agents with multiple therapeutic indications. Expert Opin Ther Patents. 2007; 17: 385-405.
    • (2007) Expert Opin Ther Patents. , vol.17 , pp. 385-405
    • Mollinedo, F.1
  • 25
    • 1842290345 scopus 로고    scopus 로고
    • Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-XL
    • Mollinedo F, Fernandez-Luna JL, Gajate C, Martin-Martin B, Benito A, Martinez-Dalmau R, Modolell M. Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-XL. Cancer Res. 1997; 57: 1320-1328.
    • (1997) Cancer Res. , vol.57 , pp. 1320-1328
    • Mollinedo, F.1    Fernandez-Luna, J.L.2    Gajate, C.3    Martin-Martin, B.4    Benito, A.5    Martinez-Dalmau, R.6    Modolell, M.7
  • 27
    • 33846243705 scopus 로고    scopus 로고
    • Edelfosine and perifosine induce selective apoptosis in multiple myeloma by recruitment of death receptors and downstream signaling molecules into lipid rafts
    • Gajate C, Mollinedo F. Edelfosine and perifosine induce selective apoptosis in multiple myeloma by recruitment of death receptors and downstream signaling molecules into lipid rafts. Blood. 2007; 109: 711-719.
    • (2007) Blood. , vol.109 , pp. 711-719
    • Gajate, C.1    Mollinedo, F.2
  • 31
    • 64549139703 scopus 로고    scopus 로고
    • Involvement of raft aggregates enriched in Fas/CD95 death-inducing signaling complex in the antileukemic action of edelfosine in Jurkat cells
    • Gajate C, Gonzalez-Camacho F, Mollinedo F. Involvement of raft aggregates enriched in Fas/CD95 death-inducing signaling complex in the antileukemic action of edelfosine in Jurkat cells. PLoS ONE. 2009; 4: e5044.
    • (2009) PLoS ONE. , vol.4 , pp. e5044
    • Gajate, C.1    Gonzalez-Camacho, F.2    Mollinedo, F.3
  • 32
    • 0035895097 scopus 로고    scopus 로고
    • The antitumor ether lipid ET-18-OCH3 induces apoptosis through translocation and capping of Fas/CD95 into membrane rafts in human leukemic cells
    • Gajate C, Mollinedo F. The antitumor ether lipid ET-18-OCH3 induces apoptosis through translocation and capping of Fas/CD95 into membrane rafts in human leukemic cells. Blood. 2001; 98: 3860-3863.
    • (2001) Blood. , vol.98 , pp. 3860-3863
    • Gajate, C.1    Mollinedo, F.2
  • 33
    • 77952487833 scopus 로고    scopus 로고
    • Lipid rafts and clusters of apoptotic signaling molecule-enriched rafts in cancer therapy
    • Mollinedo F, Gajate C. Lipid rafts and clusters of apoptotic signaling molecule-enriched rafts in cancer therapy. Future Oncol. 2010; 6: 811-821.
    • (2010) Future Oncol. , vol.6 , pp. 811-821
    • Mollinedo, F.1    Gajate, C.2
  • 34
    • 84908121687 scopus 로고    scopus 로고
    • Lipid rafts, endoplasmic reticulum and mitochondria in the antitumor action of the alkylphospholipid analog edelfosine
    • Gajate C, Mollinedo F. Lipid rafts, endoplasmic reticulum and mitochondria in the antitumor action of the alkylphospholipid analog edelfosine. Anticancer Agents Med Chem. 2014; 14: 509-527.
    • (2014) Anticancer Agents Med Chem. , vol.14 , pp. 509-527
    • Gajate, C.1    Mollinedo, F.2
  • 35
    • 84861220296 scopus 로고    scopus 로고
    • Antitumor alkyl-lysophospholipid analog edelfosine induces apoptosis in pancreatic cancer by targeting endoplasmic reticulum
    • Gajate C, Matos-da-Silva M, Dakir EL, Fonteriz RI, Alvarez J, Mollinedo F. Antitumor alkyl-lysophospholipid analog edelfosine induces apoptosis in pancreatic cancer by targeting endoplasmic reticulum. Oncogene. 2012; 31: 2627-2639.
    • (2012) Oncogene. , vol.31 , pp. 2627-2639
    • Gajate, C.1    Matos-da-Silva, M.2    Dakir, E.L.3    Fonteriz, R.I.4    Alvarez, J.5    Mollinedo, F.6
  • 38
    • 0031968488 scopus 로고    scopus 로고
    • Involvement of c-Jun NH2-terminal kinase activation and c-Jun in the induction of apoptosis by the ether phospholipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine
    • Gajate C, Santos-Beneit A, Modolell M, Mollinedo F. Involvement of c-Jun NH2-terminal kinase activation and c-Jun in the induction of apoptosis by the ether phospholipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine. Mol Pharmacol. 1998; 53: 602-612.
    • (1998) Mol Pharmacol. , vol.53 , pp. 602-612
    • Gajate, C.1    Santos-Beneit, A.2    Modolell, M.3    Mollinedo, F.4
  • 39
    • 0028947930 scopus 로고
    • Development and characterization of a conditionally immortalized human fetal osteoblastic cell line
    • Harris SA, Enger RJ, Riggs BL, Spelsberg TC. Development and characterization of a conditionally immortalized human fetal osteoblastic cell line. J Bone Miner Res. 1995; 10: 178-186.
    • (1995) J Bone Miner Res. , vol.10 , pp. 178-186
    • Harris, S.A.1    Enger, R.J.2    Riggs, B.L.3    Spelsberg, T.C.4
  • 40
    • 0036354866 scopus 로고    scopus 로고
    • Further characterization of human fetal osteoblastic hFOB 1.19 and hFOB/ER alpha cells: bone formation in vivo and karyotype analysis using multicolor fluorescent in situ hybridization
    • Subramaniam M, Jalal SM, Rickard DJ, Harris SA, Bolander ME, Spelsberg TC. Further characterization of human fetal osteoblastic hFOB 1.19 and hFOB/ER alpha cells: bone formation in vivo and karyotype analysis using multicolor fluorescent in situ hybridization. J Cell Biochem. 2002; 87: 9-15.
    • (2002) J Cell Biochem. , vol.87 , pp. 9-15
    • Subramaniam, M.1    Jalal, S.M.2    Rickard, D.J.3    Harris, S.A.4    Bolander, M.E.5    Spelsberg, T.C.6
  • 43
    • 14744281338 scopus 로고    scopus 로고
    • Bcl-XL specifically activates Bak to induce swelling and restructuring of the endoplasmic reticulum
    • Klee M, Pimentel-Muinos FX. Bcl-XL specifically activates Bak to induce swelling and restructuring of the endoplasmic reticulum. J Cell Biol. 2005; 168: 723-734.
    • (2005) J Cell Biol. , vol.168 , pp. 723-734
    • Klee, M.1    Pimentel-Muinos, F.X.2
  • 44
    • 0037417334 scopus 로고    scopus 로고
    • Caspase cleavage product of BAP31 induces mitochondrial fission through endoplasmic reticulum calcium signals, enhancing cytochrome c release to the cytosol
    • Breckenridge DG, Stojanovic M, Marcellus RC, Shore GC. Caspase cleavage product of BAP31 induces mitochondrial fission through endoplasmic reticulum calcium signals, enhancing cytochrome c release to the cytosol. J Cell Biol. 2003; 160: 1115-1127.
    • (2003) J Cell Biol. , vol.160 , pp. 1115-1127
    • Breckenridge, D.G.1    Stojanovic, M.2    Marcellus, R.C.3    Shore, G.C.4
  • 45
    • 33646171070 scopus 로고    scopus 로고
    • Stress induction of GRP78/BiP and its role in cancer
    • Li J, Lee AS. Stress induction of GRP78/BiP and its role in cancer. Curr Mol Med. 2006; 6: 45-54.
    • (2006) Curr Mol Med. , vol.6 , pp. 45-54
    • Li, J.1    Lee, A.S.2
  • 47
    • 79551600416 scopus 로고    scopus 로고
    • Fis1 and Bap31 bridge the mitochondria-ER interface to establish a platform for apoptosis induction
    • Iwasawa R, Mahul-Mellier AL, Datler C, Pazarentzos E, Grimm S. Fis1 and Bap31 bridge the mitochondria-ER interface to establish a platform for apoptosis induction. EMBO J. 2011; 30: 556-568.
    • (2011) EMBO J. , vol.30 , pp. 556-568
    • Iwasawa, R.1    Mahul-Mellier, A.L.2    Datler, C.3    Pazarentzos, E.4    Grimm, S.5
  • 48
    • 0036606540 scopus 로고    scopus 로고
    • ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats
    • Nishitoh H, Matsuzawa A, Tobiume K, Saegusa K, Takeda K, Inoue K, Hori S, Kakizuka A, Ichijo H. ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats. Genes Dev. 2002; 16: 1345-1355.
    • (2002) Genes Dev. , vol.16 , pp. 1345-1355
    • Nishitoh, H.1    Matsuzawa, A.2    Tobiume, K.3    Saegusa, K.4    Takeda, K.5    Inoue, K.6    Hori, S.7    Kakizuka, A.8    Ichijo, H.9
  • 50
    • 84931023434 scopus 로고    scopus 로고
    • Interval compressed vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide, etoposide in patients with advanced Ewing's and other Small Round Cell Sarcomas
    • Whelan J, Khan A, Sharma A, Rothermundt C, Dileo P, Michelagnoli M, Seddon B, Strausss S. Interval compressed vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide, etoposide in patients with advanced Ewing's and other Small Round Cell Sarcomas. Clin Sarcoma Res. 2012; 2: 12.
    • (2012) Clin Sarcoma Res. , vol.2 , pp. 12
    • Whelan, J.1    Khan, A.2    Sharma, A.3    Rothermundt, C.4    Dileo, P.5    Michelagnoli, M.6    Seddon, B.7    Strausss, S.8
  • 51
    • 0141996464 scopus 로고    scopus 로고
    • Microtubules, microtubuleinterfering agents and apoptosis
    • Mollinedo F, Gajate C. Microtubules, microtubuleinterfering agents and apoptosis. Apoptosis. 2003; 8: 413-450.
    • (2003) Apoptosis. , vol.8 , pp. 413-450
    • Mollinedo, F.1    Gajate, C.2
  • 52
    • 14544274160 scopus 로고    scopus 로고
    • Survival and apoptotic signals in the action of microtubule-targeting antitumor drugs
    • Mollinedo F. Survival and apoptotic signals in the action of microtubule-targeting antitumor drugs. IDrugs. 2005; 8: 127-143.
    • (2005) IDrugs. , vol.8 , pp. 127-143
    • Mollinedo, F.1
  • 53
    • 84871711842 scopus 로고    scopus 로고
    • Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
    • Tacar O, Sriamornsak P, Dass CR. Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. J Pharm Pharmacol. 2013; 65: 157-170.
    • (2013) J Pharm Pharmacol. , vol.65 , pp. 157-170
    • Tacar, O.1    Sriamornsak, P.2    Dass, C.R.3
  • 54
  • 55
    • 84926662707 scopus 로고    scopus 로고
    • Metformin, an old drug, brings a new era to cancer therapy
    • He H, Ke R, Lin H, Ying Y, Liu D, Luo Z. Metformin, an old drug, brings a new era to cancer therapy. Cancer J. 2015; 21: 70-74.
    • (2015) Cancer J. , vol.21 , pp. 70-74
    • He, H.1    Ke, R.2    Lin, H.3    Ying, Y.4    Liu, D.5    Luo, Z.6
  • 56
    • 79952348567 scopus 로고    scopus 로고
    • Caspase-4 directly activates caspase-9 in endoplasmic reticulum stress-induced apoptosis in SHSY5Y cells
    • Yamamuro A, Kishino T, Ohshima Y, Yoshioka Y, Kimura T, Kasai A, Maeda S. Caspase-4 directly activates caspase-9 in endoplasmic reticulum stress-induced apoptosis in SHSY5Y cells. J Pharmacol Sci. 2011; 115: 239-243.
    • (2011) J Pharmacol Sci. , vol.115 , pp. 239-243
    • Yamamuro, A.1    Kishino, T.2    Ohshima, Y.3    Yoshioka, Y.4    Kimura, T.5    Kasai, A.6    Maeda, S.7
  • 57
    • 59449110529 scopus 로고    scopus 로고
    • Targeting the apoptosome for cancer therapy
    • Ledgerwood EC, Morison IM. Targeting the apoptosome for cancer therapy. Clin Cancer Res. 2009; 15: 420-424.
    • (2009) Clin Cancer Res. , vol.15 , pp. 420-424
    • Ledgerwood, E.C.1    Morison, I.M.2
  • 58
    • 84874275540 scopus 로고    scopus 로고
    • Perifosine induces cell apoptosis in human osteosarcoma cells: new implication for osteosarcoma therapy?
    • Yao C, Wei JJ, Wang ZY, Ding HM, Li D, Yan SC, Yang YJ, Gu ZP. Perifosine induces cell apoptosis in human osteosarcoma cells: new implication for osteosarcoma therapy? Cell Biochem Biophys. 2013; 65: 217-227.
    • (2013) Cell Biochem Biophys. , vol.65 , pp. 217-227
    • Yao, C.1    Wei, J.J.2    Wang, Z.Y.3    Ding, H.M.4    Li, D.5    Yan, S.C.6    Yang, Y.J.7    Gu, Z.P.8
  • 60
    • 33745055718 scopus 로고    scopus 로고
    • A phase II study of perifosine (D-21226) in patients with previously untreated metastatic or locally advanced soft tissue sarcoma: A National Cancer Institute of Canada Clinical Trials Group trial
    • Knowling M, Blackstein M, Tozer R, Bramwell V, Dancey J, Dore N, Matthews S, Eisenhauer E. A phase II study of perifosine (D-21226) in patients with previously untreated metastatic or locally advanced soft tissue sarcoma: A National Cancer Institute of Canada Clinical Trials Group trial. Invest New Drugs. 2006; 24: 435-439.
    • (2006) Invest New Drugs. , vol.24 , pp. 435-439
    • Knowling, M.1    Blackstein, M.2    Tozer, R.3    Bramwell, V.4    Dancey, J.5    Dore, N.6    Matthews, S.7    Eisenhauer, E.8
  • 65
    • 84891956900 scopus 로고    scopus 로고
    • Metformin inhibits growth and sensitizes osteosarcoma cell lines to cisplatin through cell cycle modulation
    • Quattrini I, Conti A, Pazzaglia L, Novello C, Ferrari S, Picci P, Benassi MS. Metformin inhibits growth and sensitizes osteosarcoma cell lines to cisplatin through cell cycle modulation. Oncol Rep. 2014; 31: 370-375.
    • (2014) Oncol Rep. , vol.31 , pp. 370-375
    • Quattrini, I.1    Conti, A.2    Pazzaglia, L.3    Novello, C.4    Ferrari, S.5    Picci, P.6    Benassi, M.S.7
  • 66
    • 84864536555 scopus 로고    scopus 로고
    • Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts
    • Cufi S, Corominas-Faja B, Vazquez-Martin A, Oliveras-Ferraros C, Dorca J, Bosch-Barrera J, Martin-Castillo B, Menendez JA. Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts. Oncotarget. 2012; 3: 395-398.
    • (2012) Oncotarget. , vol.3 , pp. 395-398
    • Cufi, S.1    Corominas-Faja, B.2    Vazquez-Martin, A.3    Oliveras-Ferraros, C.4    Dorca, J.5    Bosch-Barrera, J.6    Martin-Castillo, B.7    Menendez, J.A.8
  • 68
    • 84893841404 scopus 로고    scopus 로고
    • Metformin sensitizes anticancer effect of dasatinib in head and neck squamous cell carcinoma cells through AMPK-dependent ER stress
    • Lin YC, Wu MH, Wei TT, Huang WC, Huang LY, Lin YT, Chen CC. Metformin sensitizes anticancer effect of dasatinib in head and neck squamous cell carcinoma cells through AMPK-dependent ER stress. Oncotarget. 2014; 5: 298-308.
    • (2014) Oncotarget. , vol.5 , pp. 298-308
    • Lin, Y.C.1    Wu, M.H.2    Wei, T.T.3    Huang, W.C.4    Huang, L.Y.5    Lin, Y.T.6    Chen, C.C.7
  • 71
    • 0027280181 scopus 로고
    • Early and selective induction of apoptosis in human leukemic cells by the alkyl-lysophospholipid ET-18-OCH3
    • Mollinedo F, Martinez-Dalmau R, Modolell M. Early and selective induction of apoptosis in human leukemic cells by the alkyl-lysophospholipid ET-18-OCH3. Biochem Biophys Res Commun. 1993; 192: 603-609.
    • (1993) Biochem Biophys Res Commun. , vol.192 , pp. 603-609
    • Mollinedo, F.1    Martinez-Dalmau, R.2    Modolell, M.3
  • 72
    • 0034657265 scopus 로고    scopus 로고
    • Induction of apoptosis in leukemic cells by the reversible microtubuledisrupting agent 2-methoxy-5-(2',3',4'-trimethoxyphenyl)-2,4,6-cycloheptatrien-1-one: protection by Bcl-2 and Bcl-XL and cell cycle arrest
    • Gajate C, Barasoain I, Andreu JM, Mollinedo F. Induction of apoptosis in leukemic cells by the reversible microtubuledisrupting agent 2-methoxy-5-(2',3',4'-trimethoxyphenyl)-2,4,6-cycloheptatrien-1-one: protection by Bcl-2 and Bcl-XL and cell cycle arrest. Cancer Res. 2000; 60: 2651-2659.
    • (2000) Cancer Res. , vol.60 , pp. 2651-2659
    • Gajate, C.1    Barasoain, I.2    Andreu, J.M.3    Mollinedo, F.4
  • 73
    • 0037388458 scopus 로고    scopus 로고
    • Rapid and selective apoptosis in human leukemic cells induced by Aplidine through a Fas/CD95-and mitochondrial-mediated mechanism
    • Gajate C, An F, Mollinedo F. Rapid and selective apoptosis in human leukemic cells induced by Aplidine through a Fas/CD95-and mitochondrial-mediated mechanism. Clin Cancer Res. 2003; 9: 1535-1545.
    • (2003) Clin Cancer Res. , vol.9 , pp. 1535-1545
    • Gajate, C.1    An, F.2    Mollinedo, F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.